Back to Search

MICHAEL KEANE, MD

MD

Pulmonary Disease Physician

NPI: 1124047600Individual

Specialties, Licenses & Credentials

Pulmonary Disease PhysicianPrimary

Internal Medicine — Pulmonary Disease

Code: 207RP1001X

A71513(CA)

Research & Publications (20)

IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome.
PMID 17182591·J Immunol·2007
7-preclinical
Inflammation and angiogenesis in fibrotic lung disease.
PMID 17195136·Semin Respir Crit Care Med·2006
6-review
Mechanisms and mediators of pulmonary fibrosis.
PMID 16390322·Crit Rev Immunol·2005
6-review
The chemokine receptor, CXCR2, mediates the tumorigenic effects of ELR+ CXC chemokines.
PMID 15136463·Chest·2004
7-preclinical
Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
PMID 14978086·J Immunol·2004
7-preclinical
The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease.
PMID 11806840·Respir Res·2002
6-review
Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome.
PMID 12444162·J Immunol·2002
7-preclinical
ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis.
PMID 11751193·Am J Respir Crit Care Med·2001
7-preclinical
IL-12 attenuates bleomycin-induced pulmonary fibrosis.
PMID 11404251·Am J Physiol Lung Cell Mol Physiol·2001
7-preclinical
Chemokine signaling in inflammation.
PMID 10807313·Crit Care Med·2000
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
200 MEDICAL PLAZA, #365,530,420,120
LOS ANGELES, CA 90095

Quick Facts

NPI
1124047600
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile